美股市场个股详情

ABCL AbCellera Biologics

添加自选

3.780
0.0000.00%

收盘价 05/01 16:00 (美东)

3.850
+0.070+1.85%

盘后 19:19 (美东)

11.11亿总市值-7411市盈率TTM

AbCellera Biologics股票讨论区

登录发表评论

Moomoo AI

02/29 21:15

Insiders at AbCellera Biologics Inc. are increasing their holdings, indicating optimism about the company's prospects. Their willingness to buy shares at a higher price suggests they see value in the company.

Insider Stock Buying Reaches US$1.61m On AbCellera Biologics

Moomoo AI

2023/12/11 02:09

KeyBanc views current lower subsector stock prices as a valuable opportunity for long-term investors. The bank advises a detailed, company-specific approach to investment, highlighting Abcellera ($6), Absci ($3), and Schrodinger ($38) for their proven track records, AI focus, and recurring revenue growth, respectively.

KeyBanc Sees Opportunity in Tech-enabled Drug Discovery Stocks

Alvinnnnnnngenius

2023/11/11 13:01

More insider loading huge and trading at bottoms now

$AbCellera Biologics(ABCL.US)$

Trytosaveabit

2023/11/09 05:12

Inside buy

$AbCellera Biologics(ABCL.US)$ Director Montalbano John S. purchased 30,000 shares of Common Stocks on Nov 6, 8, 2023 at an average price of $4.58 for a total value of $137.4K.

Alvinnnnnnngenius

2023/11/05 12:35

Quite number of insider loading this at 4.9 during sept and recently with good PR

$AbCellera Biologics(ABCL.US)$

Ondo

2023/11/05 04:36

$AbCellera Biologics(ABCL.US)$
狗庄

Trytosaveabit

2023/11/02 04:11

Update

$Prelude Therapeutics(PRLD.US)$ Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

Moomoo AI

2023/10/28 22:11

The insider transactions at AbCellera Biologics suggest an alignment of interests with shareholders. The significant insider ownership and recent purchasing imply confidence in the company's prospects, even though it has been making losses.